COST-EFFECTIVENESS ANALYSIS OF REMDESIVIR FOR THE TREATMENT OF COVID-19 HOSPITALIZED ADULTS IN MEXICO

被引:0
|
作者
Ponce-de-Leon, A. [1 ]
Azamar-Alonso, A. [2 ]
Silva-Sanchez, F. [2 ]
Chirino-Sprung, R. [2 ]
Dominguez-Esquivel, V [3 ]
Rajme-Lopez, S. [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[2] Gilead Sci Mexico S RL CV, Mexico City, DF, Mexico
[3] HS Estudios Farmacoeconom, Mexico City, DF, Mexico
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
POSC41
引用
收藏
页码:S94 / S94
页数:1
相关论文
共 50 条
  • [41] Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
    Hardik Goswami
    Adnan Alsumali
    Yiling Jiang
    Matthias Schindler
    Elizabeth R. Duke
    Joshua Cohen
    Andrew Briggs
    Amy Puenpatom
    PharmacoEconomics, 2023, 41 : 605 - 605
  • [42] The effect of remdesivir for the treatment of COVID-19 on mortality among hospitalized patients
    Breskin, Alexander
    Wiener, Catherine
    Brookhart, M. Alan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 96 - 96
  • [43] Remdesivir for the treatment of COVID-19
    Ansems, Kelly
    Grundeis, Felicitas
    Dahms, Karolina
    Mikolajewska, Agata
    Thieme, Volker
    Piechotta, Vanessa
    Metzendorf, Maria-Inti
    Stegemann, Miriam
    Benstoem, Carina
    Fichtner, Falk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (08):
  • [44] Remdesivir for the treatment of COVID-19
    Grundeis, Felicitas
    Ansems, Kelly
    Dahms, Karolina
    Thieme, Volker
    Metzendorf, Maria-Inti
    Skoetz, Nicole
    Benstoem, Carina
    Mikolajewska, Agata
    Griesel, Mirko
    Fichtner, Falk
    Stegemann, Miriam
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (01):
  • [45] Remdesivir for the Treatment of COVID-19
    Allen, Robert
    Turner, Matthew
    DeSouza, Ian S.
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (02) : 131 - 132
  • [46] REMDESIVIR IN THE TREATMENT OF COVID-19
    Rosenberg, Karen
    AMERICAN JOURNAL OF NURSING, 2021, 121 (01) : 55 - 55
  • [47] Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)-Analysis of Data from Daily Practice
    Pantazis, Nikos
    Pechlivanidou, Evmorfia
    Antoniadou, Anastasia
    Akinosoglou, Karolina
    Kalomenidis, Ioannis
    Poulakou, Garyfallia
    Milionis, Haralampos
    Panagopoulos, Periklis
    Marangos, Markos
    Katsarolis, Ioannis
    Kazakou, Pinelopi
    Dimakopoulou, Vasiliki
    Chaliasou, Anna-Louiza
    Rapti, Vasiliki
    Christaki, Eirini
    Liontos, Angelos
    Petrakis, Vasileios
    Schinas, Georgios
    Biros, Dimitrios
    Rimpa, Maria-Christina
    Touloumi, Giota
    MICROORGANISMS, 2023, 11 (08)
  • [48] Treatment of Adults Hospitalized With COVID-19 Pneumonia
    Mathew, Paul
    Feldmann, Marc
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (21): : 2122 - 2123
  • [49] Cost-effectiveness analysis of COVID-19 tests in the unified health system
    Cedro, Vinicius Queiroz Miranda
    de Lima Gomes, Stefany
    Simoes, Ana Clara Correa Duarte
    do Valle Lovato Sverzut, Tatiana
    Bertti, Keila Cristina Xavier
    Tristao, Marcelo Tadeu
    Cavalcanti, Yuri Wanderley
    Camara, Joao Victor Frazao
    Pereira, Antonio Carlos
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [50] Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
    Orangi, Stacey
    Ojal, John
    Brand, Samuel P. C.
    Orlendo, Cameline
    Kairu, Angela
    Aziza, Rabia
    Ogero, Morris
    Agweyu, Ambrose
    Warimwe, George M.
    Uyoga, Sophie
    Otieno, Edward
    Ochola-Oyier, Lynette, I
    Agoti, Charles N.
    Kasera, Kadondi
    Amoth, Patrick
    Mwangangi, Mercy
    Aman, Rashid
    Ng'ang'a, Wangari
    Adetifa, Ifedayo M. O.
    Scott, J. Anthony G.
    Bejon, Philip
    Keeling, Matt J.
    Flasche, Stefan
    Nokes, D. James
    Barasa, Edwine
    BMJ GLOBAL HEALTH, 2022, 7 (08):